Contact
searchSearch
HMP Global

Volume 12 - Issue 10 - October 2015

Insights

Interview
Antiplatelet Therapy for Peripheral Artery Disease: An Interview With Craig Walker, MD
10/03/2015
Craig Walker, MD, clinical professor of medicine at Tulane University School of Medicine and Louisiana State University School of Medicine in New Orleans, and founder, president, and medical director of the Cardiovascular Institute of the...
Craig Walker, MD, clinical professor of medicine at Tulane University School of Medicine and Louisiana State University School of Medicine in New Orleans, and founder, president, and medical director of the Cardiovascular Institute of the...
Craig Walker, MD, clinical...
10/03/2015
Vascular Disease Management
Interview
Data From the EASE Atherectomy Trial: An Interview With Tom Davis, MD
10/03/2015
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management spoke with Thomas Davis, MD, about the Endovascular Atherectomy Safety and Effectiveness (EASE) trial, an FDA-approved Investigational Device Exemption (IDE)...
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management spoke with Thomas Davis, MD, about the Endovascular Atherectomy Safety and Effectiveness (EASE) trial, an FDA-approved Investigational Device Exemption (IDE)...
At the 5th Annual Amputation...
10/03/2015
Vascular Disease Management
Interview
Subset Analysis of DEFINITIVE LE: An Interview With Lawrence A. Garcia, MD
10/03/2015
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management asked Lawrence A. Garcia, MD, to share details about subset analysis and new insights from the DEFINITIVE LE trial. The DEFINITIVE LE study was conducted at 47...
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management asked Lawrence A. Garcia, MD, to share details about subset analysis and new insights from the DEFINITIVE LE trial. The DEFINITIVE LE study was conducted at 47...
At the 5th Annual Amputation...
10/03/2015
Vascular Disease Management
Interview
The Current State of Endovascular Intervention for Peripheral Arterial Disease
10/03/2015
Rigved V. Tadwalkar, MD, MS; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of...
10/03/2015
Vascular Disease Management
Antiplatelet Therapy for Peripheral Artery Disease: An Interview With Craig Walker, MD
10/03/2015
Craig Walker, MD, clinical professor of medicine at Tulane University School of Medicine and Louisiana State University School of Medicine in New Orleans, and founder, president, and medical director of the Cardiovascular Institute of the...
Craig Walker, MD, clinical professor of medicine at Tulane University School of Medicine and Louisiana State University School of Medicine in New Orleans, and founder, president, and medical director of the Cardiovascular Institute of the...
Craig Walker, MD, clinical...
10/03/2015
Vascular Disease Management
Data From the EASE Atherectomy Trial: An Interview With Tom Davis, MD
10/03/2015
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management spoke with Thomas Davis, MD, about the Endovascular Atherectomy Safety and Effectiveness (EASE) trial, an FDA-approved Investigational Device Exemption (IDE)...
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management spoke with Thomas Davis, MD, about the Endovascular Atherectomy Safety and Effectiveness (EASE) trial, an FDA-approved Investigational Device Exemption (IDE)...
At the 5th Annual Amputation...
10/03/2015
Vascular Disease Management
Subset Analysis of DEFINITIVE LE: An Interview With Lawrence A. Garcia, MD
10/03/2015
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management asked Lawrence A. Garcia, MD, to share details about subset analysis and new insights from the DEFINITIVE LE trial. The DEFINITIVE LE study was conducted at 47...
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management asked Lawrence A. Garcia, MD, to share details about subset analysis and new insights from the DEFINITIVE LE trial. The DEFINITIVE LE study was conducted at 47...
At the 5th Annual Amputation...
10/03/2015
Vascular Disease Management
The Current State of Endovascular Intervention for Peripheral Arterial Disease
10/03/2015
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of...
10/03/2015
Vascular Disease Management

Feature

Review
Use of Covered Stents to Treat Occlusive Mesenteric Artery Disease
10/03/2015
Leonardo Reis de Souza, MD; Ying Huang, MD; Gustavo S. Oderich, MD; Peter Banga, MD
This review describes the use of covered stents in endovascular treatment of chronic mesenteric ischemia, including indications, techniques, and results.
This review describes the use of covered stents in endovascular treatment of chronic mesenteric ischemia, including indications, techniques, and results.
This review describes the use of...
10/03/2015
Vascular Disease Management

Column

Clinical Editor's Corner
Covered Stents for Mesenteric Ischemia
10/03/2015
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
The incidence of chronic mesenteric ischemia may be much higher than is traditionally reported. Optimizing interventional outcomes will be multifactorial.
The incidence of chronic mesenteric ischemia may be much higher than is traditionally reported. Optimizing interventional outcomes will be multifactorial.
The incidence of chronic...
10/03/2015
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Aortic Lesions
Gore Announces FDA Approval and First Commercial Implant of Large-Diameter Thoracic Tapers
04/03/2025
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24,...
04/03/2025
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest

October 2015 Volume 12 Issue 10

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use